- Nachrichtendetail
-
10.06.2024 14:01:53 - dpa-AFX: *ABBOTT GETS FDA CLEARANCE FOR TWO NEW OVER-THE-COUNTER CONTINUOUS GLUCOSE MONITORING SYSTEMS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Abbott Laboratories | 850103 | NYSE | 101,260 | 09.07.24 20:25:14 | -0,860 | -0,84% | 101,250 | 101,270 | 103,780 | 102,120 |
